| Conferences \ BioProcessing, Biologics & Biotherapeutics Congress \ Downstream Processing \ Agenda \ Jurgen Hubbuch |
| Register | Login |
State of the Art and Future Tools for High Throughput Process Development in the Biopharmaceutical IndustryThursday, 21 July 2011 at 10:00  Add to Calendar ▼2011-07-21 10:00:002011-07-21 11:00:00Europe/LondonState of the Art and Future Tools for High Throughput Process Development in the Biopharmaceutical IndustrySELECTBIOenquiries@selectbiosciences.comHigh throughput process development methodologies have changed process development in the biopharmaceutical industry dramatically. Hand in hand with the QbD approach by the FDA we see a shift towards a rational and platform based process development. Tools used in this methodology are high throughput screening strategies, statistical and model based design of experiments, HTS compatible analytics and data analysis. |
Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonDownstream ProcessingSELECTBIOenquiries@selectbiosciences.com
